de Jong Ellen, van der Velden Inge, Smid Anne-Marieke C, Ida Jennifer A, Reyher Kristen K, Kelton David F, Barkema Herman W
Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada.
Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.
Front Vet Sci. 2024 Aug 8;11:1417958. doi: 10.3389/fvets.2024.1417958. eCollection 2024.
Clinical mastitis (CM) treatment decision-making is a multifaceted process that remains relatively understudied, despite CM being one of the most prevalent diseases on dairy farms worldwide, contributing greatly to the use of antimicrobials in the dairy industry. This study aimed to gain insights into decision-making mechanisms employed by dairy farmers in British Columbia and Alberta, Canada, when dealing with CM.
Interviews were held with 15 dairy farmers in the Canadian provinces of British Columbia and Alberta and analyzed using reflexive thematic analysis to develop both the decision-pathway and overarching themes influencing the CM decisions by farmers in this region.
The analysis generated a decision-making process that begins with identification and classification of CM, guided by visual characteristics of milk and the udder, available milk production and quality data, presence of systemic signs, and additional diagnostics. Subsequently, CM cases are assessed based on the likelihood of cure, value of the cow, and herd goals to decide whether antimicrobial treatment is desired. Next, a treatment choice is made by evaluating severity and urgency of the case, availability of drugs and timing of the case. Finally, definition of treatment success and progression over time following the treatment decision guides the termination of treatment. Three overarching themes were generated that shape the decision-making process: 'Personal attributes', including personal approach and experiential knowledge; 'Inter-actor dynamics', such as shared decision-making and dynamics among producers, veterinarians, and milkers; and 'Moving beyond protocols', which highlights the dynamic nature of mastitis decision-making. These insights have the potential to inform the development of effective interventions to improve CM antimicrobial use that align with the reality of farming operations within Western Canada, and potentially beyond.
临床乳腺炎(CM)的治疗决策是一个多方面的过程,尽管CM是全球奶牛场中最普遍的疾病之一,且在乳制品行业中大量使用抗菌药物,但该过程仍相对缺乏研究。本研究旨在深入了解加拿大不列颠哥伦比亚省和艾伯塔省的奶农在处理CM时所采用的决策机制。
对加拿大不列颠哥伦比亚省和艾伯塔省的15位奶农进行了访谈,并采用反思性主题分析进行分析,以确定影响该地区奶农CM决策的决策路径和总体主题。
分析得出了一个决策过程,该过程始于根据牛奶和乳房的视觉特征、可用的牛奶产量和质量数据、全身症状的存在以及其他诊断方法对CM进行识别和分类。随后,根据治愈的可能性、奶牛的价值和畜群目标对CM病例进行评估,以决定是否需要进行抗菌治疗。接下来,通过评估病例的严重程度和紧迫性、药物的可用性以及病例的时间来做出治疗选择。最后,治疗成功的定义以及治疗决策后随时间的进展指导治疗的终止。产生了三个塑造决策过程的总体主题:“个人属性”,包括个人方法和经验知识;“参与者动态”,例如共同决策以及生产者、兽医和挤奶工之间的动态关系;以及“超越规程”,这突出了乳腺炎决策的动态性质。这些见解有可能为制定有效的干预措施提供信息,以改善CM抗菌药物的使用,使其与加拿大西部乃至其他地区的养殖实际情况相符合。